Skip to main content
Erschienen in:

05.08.2024 | Themenschwerpunkt

Geroscience in the continuum from healthy longevity to frailty

verfasst von: Prof. Dr. M. Cristina Polidori

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

The socioeconomic and technological developments of the past decades have enabled unique progress associated to increased life expectancy and better health for a large part of the world’s population; however, multimorbidity, frailty and disability are also on the rise. Geroscience as the new biology of aging is based on the evidence that the main risk factor for noncommunicable chronic diseases (NCD) is the aging process; however, its technology is mostly used for the scientific study of longevity and its interaction with aging medicine and geriatrics is still limited. In this perspective, the need for a tighter exchange between geroscience and geriatrics for longer health span and intrinsic capacity is discussed in the context of existing evidence and knowledge gaps.
Literatur
1.
Zurück zum Zitat Frailty (2024) Dossier. Dtsch Med Wochenschr 149(01/02):1–30 Frailty (2024) Dossier. Dtsch Med Wochenschr 149(01/02):1–30
7.
Zurück zum Zitat Polidori MC Embracing complexity of (brain) aging. Febs Lett (in press) Polidori MC Embracing complexity of (brain) aging. Febs Lett (in press)
11.
Zurück zum Zitat GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133–2161. https://doi.org/10.1016/S0140-6736(24)00757-8. Epub 2024 Apr 17. PMID: 38642570. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024 May 18;403(10440):2133–2161. https://​doi.​org/​10.​1016/​S0140-6736(24)00757-8. Epub 2024 Apr 17. PMID: 38642570.
13.
Zurück zum Zitat Ferrucci L, Tanaka T, Polidori MC Can we translate geroscience in healthcare? ZfGG Please update this one, it is in the present issue Ferrucci L, Tanaka T, Polidori MC Can we translate geroscience in healthcare? ZfGG Please update this one, it is in the present issue
18.
Zurück zum Zitat Chen et al (2023) Biomarkers of ageing: current state-of-art, challenges, and opportunities. MedComm Chen et al (2023) Biomarkers of ageing: current state-of-art, challenges, and opportunities. MedComm
19.
Zurück zum Zitat Erema VV, Yakovchik AY, Kashtanova DA et al (2022) Biological age predictors: the status quo and future trends. Int J Mol Sci 23:15103CrossRefPubMedPubMedCentral Erema VV, Yakovchik AY, Kashtanova DA et al (2022) Biological age predictors: the status quo and future trends. Int J Mol Sci 23:15103CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Moqri M, Herzog C, Poganik JR et al (2023) Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186(18):3758–3775CrossRefPubMedPubMedCentral Moqri M, Herzog C, Poganik JR et al (2023) Biomarkers of aging for the identification and evaluation of longevity interventions. Cell 186(18):3758–3775CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A (2023) Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med 29(5):1221–1231CrossRefPubMed Tian YE, Cropley V, Maier AB, Lautenschlager NT, Breakspear M, Zalesky A (2023) Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality. Nat Med 29(5):1221–1231CrossRefPubMed
22.
Zurück zum Zitat Ubaida-Mohien C, Tanaka T, Tian Q et al (2023) Blood biomarkers for healthy aging. Gerontology 69(10):1167–1174CrossRefPubMed Ubaida-Mohien C, Tanaka T, Tian Q et al (2023) Blood biomarkers for healthy aging. Gerontology 69(10):1167–1174CrossRefPubMed
23.
Zurück zum Zitat Wang Q, Hou T, Wang Q, He J, Wang L, Si J, Chen S (2023) An evaluation of aging measures: from biomarkers to clocks. Biogerontology 24(3):303–328CrossRefPubMed Wang Q, Hou T, Wang Q, He J, Wang L, Si J, Chen S (2023) An evaluation of aging measures: from biomarkers to clocks. Biogerontology 24(3):303–328CrossRefPubMed
25.
Zurück zum Zitat Hank K, Wagner M, Zank S (eds) Alternsforschung. Handbuch für Wissenschaft und Praxis Hank K, Wagner M, Zank S (eds) Alternsforschung. Handbuch für Wissenschaft und Praxis
26.
Zurück zum Zitat Marengoni A, Rizzuto D, Fratiglioni L, Antikainen R, Laatikainen T, Lehtisalo J, Peltonen M, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Ngandu T (2018) The effect of a 2-year intervention consisting of diet, physical exercise, cognitive training, and monitoring of vascular risk on chronic morbidity—the FINGER randomized controlled trial. J Am Med Dir Assoc 19(4):355–360.e1. https://doi.org/10.1016/j.jamda.2017.09.020CrossRefPubMed Marengoni A, Rizzuto D, Fratiglioni L, Antikainen R, Laatikainen T, Lehtisalo J, Peltonen M, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Ngandu T (2018) The effect of a 2-year intervention consisting of diet, physical exercise, cognitive training, and monitoring of vascular risk on chronic morbidity—the FINGER randomized controlled trial. J Am Med Dir Assoc 19(4):355–360.e1. https://​doi.​org/​10.​1016/​j.​jamda.​2017.​09.​020CrossRefPubMed
27.
Zurück zum Zitat Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC, PIONEER 6 Investigators (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 381(9):841–851. https://doi.org/10.1056/NEJMoa1901118CrossRefPubMed Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, Jeppesen OK, Lingvay I, Mosenzon O, Pedersen SD, Tack CJ, Thomsen M, Vilsbøll T, Warren ML, Bain SC, PIONEER 6 Investigators (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med 381(9):841–851. https://​doi.​org/​10.​1056/​NEJMoa1901118CrossRefPubMed
29.
Zurück zum Zitat Polidori MC, Ferrucci L Eds. Frailty in real life and its translational implications. Article Collection, Aging Clin Exp Res 2023. Polidori MC, Ferrucci L Eds. Frailty in real life and its translational implications. Article Collection, Aging Clin Exp Res 2023.
30.
Zurück zum Zitat Polidori MC, Naughton C, Roller-Wirnsberger RE Educating the workforce for age-attuned healthcare. In: Michel JP, Martin F, Walston J, Arai H, Pin TM, Kivipelto M (eds) Oxford Textbook of Geriatric Medicine, 4th edn. (in press) Polidori MC, Naughton C, Roller-Wirnsberger RE Educating the workforce for age-attuned healthcare. In: Michel JP, Martin F, Walston J, Arai H, Pin TM, Kivipelto M (eds) Oxford Textbook of Geriatric Medicine, 4th edn. (in press)
31.
Zurück zum Zitat Roller-Wirnsberger RE, Singler K, Polidori MC (eds) (2018) Learning Geriatric Medicine, Springer Roller-Wirnsberger RE, Singler K, Polidori MC (eds) (2018) Learning Geriatric Medicine, Springer
Metadaten
Titel
Geroscience in the continuum from healthy longevity to frailty
verfasst von
Prof. Dr. M. Cristina Polidori
Publikationsdatum
05.08.2024
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 5/2024
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-024-02331-2